Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Cardiovascular Device

PUBLISHER: iData Research Inc. | PRODUCT CODE: 1292443

Cover Image

PUBLISHER: iData Research Inc. | PRODUCT CODE: 1292443

Peripheral Vascular Devices Market Analysis, Size, Trends | Europe | 2023-2029 | MedSuite | Includes: Peripheral Vascular Stent Market, Stent Graft Market,Transcatheter Embolization Market & 15 more

PUBLISHED:
PAGES: 1041 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 8995
PDF (Site License)
USD 9995
PDF (Corporate License)
USD 10995

Add to Cart

Description

Table of Contents

List of Tables

In 2022, the European market for peripheral vascular devices reached a valuation of approximately €1.5 billion. As we look ahead, it is expected to experience a steady growth rate with a projected CAGR of 3.1% during the forecast period, ultimately reaching around €1.9 billion.

Our extensive medical device market research encompassed an analysis of over 50 companies operating within the peripheral vascular device market across Europe. Through our comprehensive methodology, we delved into various aspects including market sizes, unit sales, company market shares, and average sales prices (ASPs) to provide accurate forecasts.

The full report suite on the European peripheral vascular (PV) devices market offers a comprehensive analysis of a wide range of devices including peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy devices, intravascular lithotripsy (IVL) systems, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, carotid shunts, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices (VCDs), transcatheter embolization devices, and peripheral intravascular ultrasound (IVUS) catheters. Our in-depth analysis provides valuable insights into this dynamic market.

DATA TYPES INCLUDED:

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2029, and Historical Data to 2019
  • Market Drivers & Limiters for Each Peripheral Vascular Device market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

EUROPEAN PERIPHERAL VASCULAR DEVICES MARKET INSIGHTS

The COVID-19 pandemic had a significant impact on the European peripheral vascular (PV) market in 2020. Lockdown measures and procedure delays led to reduced demand and lower sales for PV device companies. However, as restrictions eased and procedures resumed, the PV market started to recover. In 2021 and 2022, there was a noticeable increase in demand for PV devices as postponed procedures were addressed. This recovery demonstrates the resilience of the PV market in Europe.

The IVL (Intravascular Lithotripsy) market in Europe has witnessed significant growth in recent years. This advanced technology employs sound waves to disrupt calcium deposits in arteries, offering a more effective and minimally invasive alternative to conventional treatments for peripheral arterial disease. The escalating prevalence of peripheral artery disease, coupled with the rising demand for less invasive treatment options, has fueled the increasing adoption of IVL in Europe.

EUROPEAN PERIPHERAL VASCULAR DEVICES MARKET SHARE INSIGHTS

In 2022, Medtronic emerged as the leading player in the European PV market, leveraging its strong presence in the stent graft segment and diverse product portfolio. The company's ability to capture significant shares in high-value markets has enabled it to bundle lower-priced products, enhancing its overall market position. Medtronic's flagship offerings, such as Admiral IN.PACT™ drug-coated balloons, Endurant™ and Valiant™ stent grafts, along with a range of stents and PTA balloons, have contributed to substantial revenue generation. Furthermore, Medtronic has established dominance in the atherectomy device market, despite its relatively smaller size in Europe.

Cook Medical secured the second-leading position in the PV market, primarily driven by its strong foothold in the stent graft segment. The company also led the inferior vena cava filter (IVCF) market, although it constitutes a smaller portion of its revenue due to the market's size. Cook Medical's Zenith® family of stent grafts stands out as the company's flagship product, contributing significantly to its overall market presence.

Boston Scientific, following its merger with BTG in 2019, initially secured the second-leading position in the European market. However, in 2022, it slipped to the third position due to market share loss to Cook Medical. Nevertheless, Boston Scientific has made notable progress in its venous treatment and transcatheter embolization portfolios after the acquisition, establishing a leading position in both markets. With a comprehensive portfolio for treating venous diseases, Boston Scientific is expected to gradually regain market share in the overall PV market over time.

RESEARCH REGIONAL COVERAGE

Throughout our research series, iData Research has extensively covered numerous countries, providing in-depth analysis and insights. Some of the countries we have focused on include:

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Benelux (Belgium, Netherlands, and Luxembourg)
  • Switzerland
  • Austria
  • Portugal
  • Scandinavia (Denmark, Finland, Norway and Sweden)

SEGMENTS COVERED

  • Peripheral Vascular Stent Market
  • PTA Balloon Catheter Market
  • Drug-Coated Balloon Market
  • Atherectomy Device Market
  • Intravascular Lithotripsy Market
  • CTO Device Market
  • Surgical Graft Market
  • Stent Graft Market
  • Embolic Protection Device Market
  • Peripheral Thrombus Management Market
  • Inferior Vena Cava Filter Market
  • Carotid Shunt Market
  • Diagnostic and Interventional Catheter Market
  • Diagnostic and Interventional Guidewire Market
  • Introducer Sheath Market
  • Vascular Closure Device Market
  • Transcatheter Embolization Market
  • Peripheral IVUS Market

RESEARCH SCOPE SUMMARY

  • Regions: Western Europe, Central & Eastern Europe
  • Base Year: 2022
  • Forecast: 2023-2029
  • Historical Data: 2019-2022
  • Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
  • Qualitative Coverage: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
  • Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE IDATA?

  • Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
  • Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
  • Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
  • Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Show more
Product Code: iDATA_EUPV23

TABLE OF CONTENT

  • Table of Contents
  • List of Figures
  • List of Charts

Executive summary

European Peripheral Vascular Device Market Overview

Competitive Analysis

Market Trends

Market Developments

Procedure Numbers

Markets Included

Key Report Updates

Version History

Research methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

Impact of covid-19 on THE European peripheral vascular device Market

  • 2.1. Introduction
  • 2.2. Country Profile
  • 2.3. Analysis By Market Segment
    • 2.3.1. Worst Case Scenario
    • 2.3.2. Base Case Scenario
    • 2.3.3. Best Case Scenario

Disease Overview

  • 3.1. Basic Anatomy
  • 3.2. Disease Treatments & Diagnostics
    • 3.2.1. Aortic Aneurysms
    • 3.2.2. Atherosclerosis
    • 3.2.3. Peripheral Arterial Disease (PAD)
    • 3.2.4. Deep Vein Thrombosis
    • 3.2.5. Pulmonary Embolism
  • 3.3. Patient Demographics
    • 3.3.1. Aortic Aneurysms
    • 3.3.2. Atherosclerosis
    • 3.3.3. Peripheral Arterial Disease (PAD)
    • 3.3.4. Deep Vein Thrombosis
    • 3.3.5. Pulmonary Embolism

Product Assessment

  • 4.1. Introduction
  • 4.2. Product Portfolios
    • 4.2.1. Peripheral Vascular Stent
    • 4.2.2. PTA Balloon Catheter
    • 4.2.3. Drug-Coated Balloon
    • 4.2.4. Atherectomy Device
    • 4.2.5. Intravascular Lithotripsy Market
    • 4.2.6. Chronic Total Occlusion
    • 4.2.7. Surgical Graft
    • 4.2.8. Stent Graft
    • 4.2.9. Embolic Protection
    • 4.2.10. Peripheral Thrombus Management
    • 4.2.11. Inferior Vena Cava Filter and Retrieval
    • 4.2.12. Carotid Shunt
    • 4.2.13. Diagnostic and Interventional Catheter
    • 4.2.14. Diagnostic and Interventional Guidewire
    • 4.2.15. Introducer Sheath
    • 4.2.16. Vascular Closure Device
    • 4.2.17. Transcatheter Embolization Device
    • 4.2.18. Peripheral IVUS Catheter
  • 4.3. Regulatory Issues and Recalls
    • 4.3.1. Peripheral Vascular Stent
    • 4.3.2. PTA Balloon Catheter
    • 4.3.3. Atherectomy Device
    • 4.3.4. Intravascular Lithotripsy Market
    • 4.3.5. Chronic Total Occlusion
    • 4.3.6. Surgical Graft
    • 4.3.7. Stent Graft
    • 4.3.8. Peripheral Thrombus Management
    • 4.3.9. Peripheral Thrombus Management Devices
    • 4.3.10. Inferior Vena Cava Filter and Retrieval
    • 4.3.11. Diagnostic and Interventional Catheter
    • 4.3.12. Diagnostic and Interventional Guidewire
    • 4.3.13. Introducer Sheath
    • 4.3.14. Transcatheter Embolization Device
    • 4.3.15. Peripheral IVUS Catheter
  • 4.4. Clinical Trials
    • 4.4.1. Peripheral Vascular Stent
    • 4.4.2. PTA Balloon Catheter
    • 4.4.3. Drug-Coated Balloon
    • 4.4.4. Atherectomy Device
    • 4.4.5. Intravascular Lithotripsy
    • 4.4.6. Surgical Graft
    • 4.4.7. Stent Graft
    • 4.4.8. Embolic Protection
    • 4.4.9. Peripheral Thrombus Management
    • 4.4.10. Inferior Vena Cava Filter & Retrieval
    • 4.4.11. Vascular Closure Device
    • 4.4.12. Transcatheter Embolization Device

European Peripheral vascular device Market Overview

  • 5.1. Introduction
    • 5.1.1. Atherosclerosis
    • 5.1.2. Peripheral Arterial Disease
  • 5.2. Currency Exchange Rate
  • 5.3. Market Overview & Trend Analysis
  • 5.4. Drivers and Limiters
    • 5.4.1. Market Drivers
    • 5.4.2. Market Limiters
  • 5.5. Competitive Market Share Analysis
  • 5.6. Mergers and Acquisitions
  • 5.7. Company Profiles
    • 5.7.1. Abbott
    • 5.7.2. Becton Dickinson
    • 5.7.3. Boston Scientific
    • 5.7.4. Cardinal Health
    • 5.7.5. Cardiovascular Systems, Inc.
    • 5.7.6. Cook Medical
    • 5.7.7. Medtronic
    • 5.7.8. Penumbra
    • 5.7.9. Philips
    • 5.7.10. Shockwave Medical
    • 5.7.11. Silk Road Medical
    • 5.7.12. Terumo
    • 5.7.13. W.L. Gore
  • 5.8. SWOT Analysis
    • 5.8.1. Abbott
    • 5.8.2. Becton Dickinson
    • 5.8.3. Boston Scientific
    • 5.8.4. Cardinal Health
    • 5.8.5. Cardiovascular Systems, Inc.
    • 5.8.6. Cook Medical
    • 5.8.7. Medtronic
    • 5.8.8. Penumbra
    • 5.8.9. Philips
    • 5.8.10. Shockwave Medical
    • 5.8.11. Silk Road Medical
    • 5.8.12. Terumo
    • 5.8.13. W.L. Gore

Country Profiles

  • 6.1. Introduction
    • 6.1.1. Population
    • 6.1.2. GDP Per Capita
    • 6.1.3. Price Index
  • 6.2. Germany
  • 6.3. France
  • 6.4. United Kingdom
  • 6.5. Italy
  • 6.6. Spain
  • 6.7. Benelux
  • 6.8. Scandinavia
  • 6.9. Austria
  • 6.10. Switzerland
  • 6.11. Portugal

Procedure Numbers

  • 7.1. Procedures
    • 7.1.1. Peripheral Vascular Stent Procedures
      • 7.1.1.1. Arterial Stent Procedures
      • 7.1.1.1.1. Bare-Metal Stent Procedures
      • 7.1.1.1.2. Covered Stent Procedures
      • 7.1.1.1.3. Drug-Eluting Stent Procedures
      • 7.1.1.2. Venous Stent Procedures
    • 7.1.2. PTA Balloon Catheter Procedures
    • 7.1.3. Drug-Coated Balloon Procedures
    • 7.1.4. Atherectomy Device Procedures
      • 7.1.4.1. Laser Atherectomy Device Procedures
      • 7.1.4.2. Mechanical Atherectomy Device Procedures
    • 7.1.5. Intravascular Lithotripsy Procedures
      • 7.1.5.1. SFA and Iliac Lithotripsy Procedures
      • 7.1.5.2. BTK Lithotripsy Procedures
    • 7.1.6. CTO Device Procedures
      • 7.1.6.1. Re-Entry CTO Procedures
      • 7.1.6.2. Recanalization CTO Procedures
    • 7.1.7. Surgical Graft Procedures
      • 7.1.7.1. Total Surgical Graft Procedures by Material
      • 7.1.7.1.1. Polyester Surgical Graft Procedures
      • 7.1.7.1.2. ePTFE Surgical Graft Procedures
      • 7.1.7.2. Total Surgical Graft Procedures by Indication
      • 7.1.7.2.1. Lower-Limb Surgical Graft Procedures
      • 7.1.7.2.2. AV Access Surgical Graft Procedures
      • 7.1.7.2.3. Aorta Repair Surgical Graft Procedures
      • 7.1.7.2.4. Extra-Anatomical Bypass Surgical Graft Procedures
    • 7.1.8. Stent Graft Procedures
      • 7.1.8.1. AAA Stent Graft Procedures
      • 7.1.8.2. Fenestrated Stent Graft Procedures
      • 7.1.8.3. TAA Stent Graft Procedures
    • 7.1.9. Embolic Protection Device Procedures
      • 7.1.9.1. Carotid EPD Procedures
      • 7.1.9.2. Renal EPD Procedures
      • 7.1.9.3. Lower-Limb EPD Procedures
    • 7.1.10. Peripheral Thrombus Management Procedures
      • 7.1.10.1. Traditional Thrombectomy Device Procedures
      • 7.1.10.2. Pharmacomechanical Thrombectomy Device Procedures
    • 7.1.11. IVCF Placement Procedures
      • 7.1.11.1. Retrievable IVCF Procedures
      • 7.1.11.2. Permanent IVCF Procedures
    • 7.1.12. Carotid Shunt Procedures
    • 7.1.13. Vascular Closure Device Procedures
      • 7.1.13.1. Total Vascular Closure Device Procedures by Device Type
      • 7.1.13.1.1. Small-Bore Invasive VCD Procedures
      • 7.1.13.1.2. Large-Bore Invasive VCD Procedures
      • 7.1.13.1.3. Non-Invasive VCD Procedures
      • 7.1.13.2. Total Vascular Closure Device Procedures by Approach
      • 7.1.13.2.1. Radial VCD Procedures
      • 7.1.13.2.2. Femoral VCD Procedures
    • 7.1.14. Transcatheter Embolization Procedures
      • 7.1.14.1. Particle Embolization Procedures
      • 7.1.14.1.1. PVA Particle Procedures
      • 7.1.14.1.2. Microsphere Procedures
      • 7.1.14.1.3. Drug-Eluting Particle Procedures
      • 7.1.14.1.4. Radioactive Particle Procedures
      • 7.1.14.2. Coil Embolization Procedures
      • 7.1.14.2.1. Pushable Coil Procedures
      • 7.1.14.2.2. Detachable Coil Procedures
      • 7.1.14.3. Liquid Embolics Procedures
      • 7.1.14.4. Plug Embolization Procedures
    • 7.1.15. Peripheral IVUS Procedures

Peripheral Vascular Stent Market

  • 8.1. Introduction
    • 8.1.1. Peripheral Arterial Stents
      • 8.1.1.1. Off-Label Use
      • 8.1.1.2. Covered Stents
      • 8.1.1.3. Drug-Eluting Stents
      • 8.1.1.4. Stent Length
    • 8.1.2. Venous Stents
  • 8.2. Market Overview
  • 8.3. Market Analysis and Forecast
    • 8.3.1. Arterial Stent Market
      • 8.3.1.1. Total Bare-Metal Stent Market
      • 8.3.1.1.1. Bare-Metal Carotid Stent Market
      • 8.3.1.1.2. Bare-Metal Iliac Stent Market
      • 8.3.1.1.3. Bare-Metal Renal Stent Market
      • 8.3.1.1.4. Bare-Metal Fem-Pop Stent Market
      • 8.3.1.1.5. Bare-Metal Infra-Pop Stent Market
      • 8.3.1.2. Covered Stent Market
      • 8.3.1.3. Drug-Eluting Stent Market
    • 8.3.2. Venous Stent Market
  • 8.4. Unit Analysis
    • 8.4.1. Bare-Metal Stent Units Sold by Delivery Platform
      • 8.4.1.1. Self-Expanding Bare-Metal Stent Units
      • 8.4.1.2. Balloon-Expanding Bare-Metal Stent Units
    • 8.4.2. Bare-Metal Stent Units Sold by Stent Length
      • 8.4.2.1. Bare-Metal Carotid Stent Units
      • 8.4.2.2. Bare-Metal Iliac Stent Units
      • 8.4.2.3. Bare-Metal Renal Stent Units
      • 8.4.2.4. Bare-Metal Fem-Popliteal Stent Units
    • 8.4.3. Covered Stent Units Sold by Delivery Platform
      • 8.4.3.1. Iliac Covered Stent Units
      • 8.4.3.2. Fem-Pop Covered Stent Units
      • 8.4.3.3. AV Access Covered Stent Units
    • 8.4.4. Drug-Eluting Stent Units Sold by Delivery Platform
      • 8.4.4.1. SFA Drug-Eluting Stent Units
      • 8.4.4.2. Infra-Pop Drug-Eluting Stent Units
  • 8.5. Drivers and Limiters
    • 8.5.1. Market Drivers
    • 8.5.2. Market Limiters
  • 8.6. Competitive Market Share Analysis

PTA Balloon Catheter Market

  • 9.1. Introduction
    • 9.1.1. Types of PTA Balloon Catheters
  • 9.2. Market Overview
  • 9.3. Market Analysis and Forecast
    • 9.3.1. Total PTA Balloon Catheter Market
    • 9.3.2. Standard PTA Balloon Catheter Market
    • 9.3.3. High-Pressure PTA Balloon Catheter Market
    • 9.3.4. Large PTA Balloon Catheter Market
    • 9.3.5. Small PTA Balloon Catheter Market
    • 9.3.6. Specialty PTA Balloon Catheter Market
  • 9.4. Drivers and Limiters
    • 9.4.1. Market Drivers
    • 9.4.2. Market Limiters
  • 9.5. Competitive Market Share Analysis

Drug-Coated Balloon Market

  • 10.1. Introduction
  • 10.2. Market Analysis and Forecast
  • 10.3. Drivers and Limiters
    • 10.3.1. Market Drivers
    • 10.3.2. Market Limiters
  • 10.4. Competitive Market Share Analysis

Atherectomy Device Market

  • 11.1. Introduction
  • 11.2. Market Overview
  • 11.3. Market Analysis and Forecast
    • 11.3.1. Total Atherectomy Device Market
    • 11.3.2. Laser Atherectomy Device Market
    • 11.3.3. Mechanical Atherectomy Device Market
  • 11.4. Drivers and Limiters
    • 11.4.1. Market Drivers
    • 11.4.2. Market Limiters
  • 11.5. Competitive Market Share Analysis

Intravascular lithotripsy Market

  • 12.1. Introduction
  • 12.2. Market Analysis and Forecast
  • 12.3. Drivers and Limiters
    • 12.3.1. Market Drivers
    • 12.3.2. Market Limiters
  • 12.4. Competitive Market Share Analysis

Chronic total occlusion device Market

  • 13.1. Introduction
  • 13.2. Market Overview
  • 13.3. Market Analysis and Forecast
    • 13.3.1. Total CTO Device Market
    • 13.3.2. Re-Entry Device Market
    • 13.3.3. Recanalization Device Market
  • 13.4. Drivers and Limiters
    • 13.4.1. Market Drivers
    • 13.4.2. Market Limiters
  • 13.5. Competitive Market Share Analysis

Surgical Graft Market

  • 14.1. Introduction
  • 14.2. Market Overview
  • 14.3. Market Analysis and Forecast
    • 14.3.1. Total Lower-Limb Surgical Graft Market
      • 14.3.1.1. Above-the-Knee Surgical Graft Market
      • 14.3.1.2. Below-the-Knee Surgical Graft Market
    • 14.3.2. AV Access Surgical Graft Market
    • 14.3.3. Total Aorta Repair Surgical Graft Market
      • 14.3.3.1. Abdominal Aortic Aneurysm Surgical Graft Market
      • 14.3.3.2. Thoracic Aortic Aneurysm Surgical Graft Market
    • 14.3.4. Extra-Anatomical Bypass Surgical Graft Market
  • 14.4. Unit Analysis
    • 14.4.1. Surgical Graft Units Sold by Material
      • 14.4.1.1. Polyester Surgical Graft Units
      • 14.4.1.2. ePTFE Surgical Graft Units
  • 14.5. Drivers and Limiters
    • 14.5.1. Market Drivers
    • 14.5.2. Market Limiters
  • 14.6. Competitive Market Share Analysis

Stent graft Market

  • 15.1. Introduction
  • 15.2. Market Overview
  • 15.3. Market Analysis and Forecast
    • 15.3.1. Total Stent Graft Market
    • 15.3.2. AAA Stent Graft Market
    • 15.3.3. TAA Stent Graft Market
    • 15.3.4. Fenestrated Stent Graft Market
  • 15.4. Drivers and Limiters
    • 15.4.1. Market Drivers
    • 15.4.2. Market Limiters
  • 15.5. Competitive Market Share Analysis

Embolic Protection Device Market

  • 16.1. Introduction
    • 16.1.1. Protection Mechanism
      • 16.1.1.1. Filter Basket
      • 16.1.1.2. Distal Balloon Occlusion
      • 16.1.1.3. Flow Redirection
  • 16.2. Market Overview
  • 16.3. Market Analysis and Forecast
    • 16.3.1. Total Embolic Protection Device Market
    • 16.3.2. Carotid Embolic Protection Device Market
    • 16.3.3. Renal Embolic Protection Device Market
    • 16.3.4. Lower-Limb Embolic Protection Device Market
  • 16.4. Drivers and Limiters
    • 16.4.1. Market Drivers
    • 16.4.2. Market Limiters
  • 16.5. Competitive Market Share Analysis

Peripheral Thrombus Management Market

  • 17.1. Introduction
    • 17.1.1. AV Access Thrombectomy Devices
    • 17.1.2. Other Peripheral Applications of Thrombectomy Devices
  • 17.2. Market Overview
  • 17.3. Market Analysis and Forecast
    • 17.3.1. Total Peripheral Thrombus Management Market
    • 17.3.2. Traditional Thrombectomy Device Market
    • 17.3.3. Pharmacomechanical Thrombectomy Device Market
  • 17.4. Drivers and Limiters
    • 17.4.1. Market Drivers
    • 17.4.2. Market Limiters
  • 17.5. Competitive Market Share Analysis

Inferior vena cava filter Market

  • 18.1. Introduction
  • 18.2. Market Overview
  • 18.3. Market Analysis and Forecast
    • 18.3.1. Total Inferior Vena Cava Filter Market
    • 18.3.2. Retrievable IVCF Market
    • 18.3.3. Permanent IVCF Market
  • 18.4. Drivers and Limiters
    • 18.4.1. Market Drivers
    • 18.4.2. Market Limiters
  • 18.5. Competitive Market Share Analysis

Carotid shunt Market

  • 19.1. Introduction
  • 19.2. Market Analysis and Forecast
  • 19.3. Drivers and Limiters
    • 19.3.1. Market Drivers
    • 19.3.2. Market Limiters
  • 19.4. Competitive Market Share Analysis

Diagnostic and Interventional Catheter Market

  • 20.1. Introduction
  • 20.2. Market Overview
  • 20.3. Market Analysis and Forecast
    • 20.3.1. Total Diagnostic and Interventional Catheter Market
    • 20.3.2. Total Diagnostic Catheter Market
      • 20.3.2.1. Standard Diagnostic Catheter Market
      • 20.3.2.2. Hydrophilic Diagnostic Catheter Market
    • 20.3.3. Support Catheter Market
  • 20.4. Drivers and Limiters
    • 20.4.1. Market Drivers
    • 20.4.2. Market Limiters
  • 20.5. Competitive Market Share Analysis

Diagnostic and interventional guidewire Market

  • 21.1. Introduction
  • 21.2. Market Overview
  • 21.3. Market Analysis and Forecast
    • 21.3.1. Total Diagnostic and Interventional Guidewire Market
    • 21.3.2. Standard Guidewire Market
    • 21.3.3. Hydrophilic Guidewire Market
  • 21.4. Drivers and Limiters
    • 21.4.1. Market Drivers
    • 21.4.2. Market Limiters
  • 21.5. Competitive Market Share Analysis

Introducer sheath Market

  • 22.1. Introduction
  • 22.2. Market Overview
  • 22.3. Market Analysis and Forecast
    • 22.3.1. Total Introducer Sheath Market
    • 22.3.2. Standard Introducer Sheath Market
    • 22.3.3. Guiding Introducer Sheath Market
  • 22.4. Drivers and Limiters
    • 22.4.1. Market Drivers
    • 22.4.2. Market Limiters
  • 22.5. Competitive Market Share Analysis

Vascular Closure Device Market

  • 23.1. Introduction
  • 23.2. Market Overview
    • 23.2.1. Vascular Closure Device Market Overview by Device Type
    • 23.2.2. Vascular Closure Device Market Overview by Approach
  • 23.3. Market Analysis and Forecast
    • 23.3.1. Total Vascular Closure Device Market by Device Type
      • 23.3.1.1. Total Invasive Vascular Closure Device Market
      • 23.3.1.1.1. Small-Bore Vascular Closure Device Market
      • 23.3.1.1.2. Large-Bore Vascular Closure Device Market
      • 23.3.1.2. Non-Invasive Vascular Closure Device Market
    • 23.3.2. Total Vascular Closure Device Market by Approach
      • 23.3.2.1. Radial Vascular Closure Device Market
      • 23.3.2.2. Femoral Vascular Closure Device Market
  • 23.4. Drivers and Limiters
    • 23.4.1. Market Drivers
    • 23.4.2. Market Limiters
  • 23.5. Competitive Market Share Analysis

Transcatheter Embolization Market

  • 24.1. Introduction
    • 24.1.1. Particle Embolic Devices
    • 24.1.2. Coil Embolic Devices
    • 24.1.3. Liquid Embolic Devices
    • 24.1.4. Vascular Plugs
  • 24.2. Market Overview
  • 24.3. Market Analysis and Forecast
    • 24.3.1. Particle Embolization Market
      • 24.3.1.1. PVA Particle Market
      • 24.3.1.2. Microsphere Market
      • 24.3.1.3. Drug-Eluting Particle Market
      • 24.3.1.4. Radioactive Particle Market
    • 24.3.2. Coil Embolization Market
      • 24.3.2.1. Pushable Coil Market
      • 24.3.2.2. Detachable Coil Market
    • 24.3.3. Liquid Embolization Market
    • 24.3.4. Plug Embolization Market
  • 24.4. Drivers and Limiters
    • 24.4.1. Market Drivers
    • 24.4.2. Market Limiters
  • 24.5. Competitive Market Share Analysis

Peripheral ivus Market

  • 25.1. Introduction
  • 25.2. Market Analysis and Forecast
  • 25.3. Drivers and Limiters
    • 25.3.1. Market Drivers
    • 25.3.2. Market Limiters
  • 25.4. Competitive Market Share Analysis

Abbreviations

Show more
Product Code: iDATA_EUPV23

LIST OF CHARTS

  • Chart 1-1: Peripheral Vascular Device Market by Segment, Europe, 2022 - 2029
  • Chart 1-2: Peripheral Vascular Device Market Overview, Europe, 2022 & 2029
  • Chart 2-1: Multi-Scenario Peripheral Vascular Device Market Forecast, Europe, 2019 - 2029 (€M)
  • Chart 5-1: Peripheral Vascular Device Market by Segment, Europe, 2019 - 2029
  • Chart 5-2: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022
  • Chart 6-1: Country Profile, Germany, 2022
  • Chart 6-2: Country Profile, France, 2022
  • Chart 6-3: Country Profile, United Kingdom, 2022
  • Chart 6-4: Country Profile, Italy, 2022
  • Chart 6-5: Country Profile, Spain, 2022
  • Chart 6-6: Country Profile, Benelux, 2022
  • Chart 6-7: Country Profile, Scandinavia, 2022
  • Chart 6-8: Country Profile, Austria, 2022
  • Chart 6-9: Country Profile, Switzerland, 2022
  • Chart 6-10: Country Profile, Portugal, 2022
  • Chart 7-1: Peripheral Vascular Device Procedures by Segment, Europe, 2019 - 2029
  • Chart 8-1: Peripheral Vascular Stent Market by Segment, Europe, 2019 - 2029
  • Chart 8-2: Leading Competitors, Peripheral Vascular Stent Market, Europe, 2022
  • Chart 9-1: PTA Balloon Catheter Market by Segment, Europe, 2019 - 2029
  • Chart 9-2: Leading Competitors, PTA Balloon Catheter Market, Europe, 2022
  • Chart 10-1: Drug-Coated Balloon Market, Europe, 2019 - 2029
  • Chart 10-2: Leading Competitors, Drug-Coated Balloon Market, Europe, 2022
  • Chart 11-1: Atherectomy Device Market by Segment, Europe, 2019 - 2029
  • Chart 11-2: Leading Competitors, Atherectomy Device Market, Europe, 2022
  • Chart 12-1: Intravascular Lithotripsy Market by Segment, Europe, 2019 - 2029
  • Chart 13-1: CTO Device Market by Segment, Europe, 2019 - 2029
  • Chart 13-2: Leading Competitors, CTO Device Market, Europe, 2022
  • Chart 14-1: Surgical Graft Market by Segment, Europe, 2019 - 2029
  • Chart 14-2: Leading Competitors, Surgical Graft Market, Europe, 2022
  • Chart 15-1: Stent Graft Market by Segment, Europe, 2019 - 2029
  • Chart 15-2: Leading Competitors, Stent Graft Market, Europe, 2022
  • Chart 16-1: Embolic Protection Device Market by Segment, Europe, 2019 - 2029
  • Chart 16-2: Leading Competitors, Embolic Protection Device Market, Europe, 2022
  • Chart 17-1: Peripheral Thrombus Management Market by Segment, Europe, 2019 - 2029
  • Chart 17-2: Leading Competitors, Peripheral Thrombus Management Market, Europe, 2022
  • Chart 18-1: Inferior Vena Cava Filter Market by Segment, Europe, 2019 - 2029
  • Chart 18-2: Leading Competitors, Inferior Vena Cava Filter Market, Europe, 2022
  • Chart 19-1: Carotid Shunt Market, Europe, 2019 - 2029
  • Chart 19-2: Leading Competitors, Carotid Shunt Market, Europe, 2022
  • Chart 20-1: Diagnostic and Interventional Catheter Market by Segment, Europe, 2019 - 2029
  • Chart 20-2: Leading Competitors, Diagnostic and Interventional Catheter Market, Europe, 2022
  • Chart 21-1: Diagnostic and Interventional Guidewire Market by Segment, Europe, 2019 - 2029
  • Chart 21-2: Leading Competitors, Diagnostic and Interventional Guidewire Market, Europe, 2022
  • Chart 22-1: Introducer Sheath Market by Segment, Europe, 2019 - 2029
  • Chart 22-2: Leading Competitors, Introducer Sheath Market, Europe, 2022
  • Chart 23-1: Vascular Closure Device Market by Segment, Europe, 2019 - 2029
  • Chart 23-2: Leading Competitors, Vascular Closure Device Market, Europe, 2022
  • Chart 24-1: Transcatheter Embolization Market by Segment, Europe, 2019 - 2029
  • Chart 24-2: Leading Competitors, Transcatheter Embolization Market, Europe, 2022
  • Chart 25-1: Peripheral IVUS Market, Europe, 2019 - 2029
  • Chart 25-2: Leading Competitors, Peripheral IVUS Market, Europe, 2022

LIST OF FIGURES

  • Figure 1-1: Peripheral Vascular Device Market Share Ranking by Segment, Europe, 2022 (1 of 4)
  • Figure 1-2: Peripheral Vascular Device Market Share Ranking by Segment, Europe, 2022 (2 of 4)
  • Figure 1-3: Peripheral Vascular Device Market Share Ranking by Segment, Europe, 2022 (3 of 4)
  • Figure 1-4: Peripheral Vascular Device Market Share Ranking by Segment, Europe, 2022 (4 of 4)
  • Figure 1-5: Companies Researched in This Report
  • Figure 1-6: Factors Impacting the Peripheral Market by Segment, Europe (1 of 4)
  • Figure 1-7: Factors Impacting the peripheral Market by Segment, Europe (2 of 4)
  • Figure 1-8: Factors Impacting the peripheral Market by Segment, Europe (3 of 4)
  • Figure 1-9: Factors Impacting the peripheral Market by Segment, Europe (4 of 4)
  • Figure 1-10: Recent Events in the Peripheral Vascular Device Market, Europe, 2019 - 2023
  • Figure 1-11: Peripheral Vascular Device Procedures Covered, Europe (1 of 3)
  • Figure 1-12: Peripheral Vascular Device Procedures Covered, Europe (2 of 3)
  • Figure 1-13: Peripheral Vascular Device Procedures Covered, Europe (3 of 3)
  • Figure 1-14: Peripheral Vascular Device Markets Covered, Europe (1 of 3)
  • Figure 1-15: Peripheral Vascular Device Markets Covered, Europe (2 of 3)
  • Figure 1-16: Peripheral Vascular Device Markets Covered, Europe (3 of 3)
  • Figure 1-17: Key Report Updates
  • Figure 1-18: Version History
  • Figure 2-1: Peripheral Vascular Device Market by Segment, Worst Case Scenario, Europe, 2019 - 2029 (€M) (1 of 2)
  • Figure 2-2: Peripheral Vascular Device Market by Segment, Worst Case Scenario, Europe, 2019 - 2029 (€M) (2 of 2)
  • Figure 2-3: Peripheral Vascular Device Market by Segment, Base Case Scenario, Europe, 2019 - 2029 (€M) (1 of 2)
  • Figure 2-4: Peripheral Vascular Device Market by Segment, Base Case Scenario, Europe, 2019 - 2029 (€M) (2 of 2)
  • Figure 2-5: Peripheral Vascular Device Market by Segment, Best Case Scenario, Europe, 2019 - 2029 (€M) (1 of 2)
  • Figure 2-6: Peripheral Vascular Device Market by Segment, Best Case Scenario, Europe, 2019 - 2029 (€M) (2 of 2)
  • Figure 4-1: Peripheral Vascular Stent by Company (1 of 2)
  • Figure 4-2: Peripheral Vascular Stent by Company (2 of 2)
  • Figure 4-3: PTA Balloon Catheter by Company (1 of 3)
  • Figure 4-4: PTA Balloon Catheter by Company (2 of 3)
  • Figure 4-5: PTA Balloon Catheter by Company (3 of 3)
  • Figure 4-6: Drug-Coated Balloon by Company
  • Figure 4-7: Atherectomy Device by Company (1 of 2)
  • Figure 4-8: Atherectomy Device by Company (2 of 2)
  • Figure 4-9: Lithotripsy Device by Company
  • Figure 4-10: Chronic Total Occlusion Device by Company
  • Figure 4-11: Surgical Graft by Company (1 of 2)
  • Figure 4-12: Surgical Graft by Company (2 of 2)
  • Figure 4-13: Stent Graft by Company
  • Figure 4-14: Embolic Protection Device by Company
  • Figure 4-15: Peripheral Thrombus Management by Company
  • Figure 4-16: Inferior Vena Cava Filter & Retrieval Device by Company (1 of 2)
  • Figure 4-17: Inferior Vena Cava Filter & Retrieval Device by Company (2 of 2)
  • Figure 4-18: Carotid Shunt by Company
  • Figure 4-19: Diagnostic and Interventional Catheters by Company (1 of 2)
  • Figure 4-20: Diagnostic and Interventional Catheters by Company (2 of 2)
  • Figure 4-21: Diagnostic and Interventional Guidewire by Company (1 of 3)
  • Figure 4-22: Diagnostic and Interventional Guidewire by Company (2 of 3)
  • Figure 4-23: Diagnostic and Interventional Guidewire by Company (3 of 3)
  • Figure 4-24: Introducer Sheath by Company (1 of 2)
  • Figure 4-25: Introducer Sheath by Company (2 of 2)
  • Figure 4-26: Vascular Closure Device by Company
  • Figure 4-27: Transcatheter Embolization Devices by Company (1 of 2)
  • Figure 4-28: Transcatheter Embolization Devices by Company (2 of 2)
  • Figure 4-29: Peripheral IVUS Catheter by Company
  • Figure 4-30: Class 2 Device Recall VENOVO Venous Stent System
  • Figure 4-31: Class 1 Device Recall VICI VENOUS STENT System
  • Figure 4-32: Class 2 Device Recall ELUVIA
  • Figure 4-33: Class 2 Device Recall PALMAZ GENESIS
  • Figure 4-34: Class 2 Device Recall S.M.A.R.T. Flex
  • Figure 4-35: Class 1 Device Recall PRECISE PRO RX CAROTID STENT Implant System
  • Figure 4-36: Class 2 Device Recall Cordis S.M.A.R.T. CONTROL /S.M.A.R.T. Vascular Stent System
  • Figure 4-37: Class 2 Device Recall S.M.A.R.T. Nitinol Stent System and the S.M.A.R.T. Control Nitinol Stent System
  • Figure 4-38: Class 2 Device Recall Cordis Precise Nitinol Stent System
  • Figure 4-39: Class 2 Device Recall Formula 418 Renal BalloonExpandable Stent
  • Figure 4-40: Class 2 Device Recall Zilver 635 Biliary Stent
  • Figure 4-41: Class 2 Device Recall Zilver 518 Biliary Stent
  • Figure 4-42: Class 1 Device Recall Atrium
  • Figure 4-43: Class 2 Device Recall Everflex Selfexpanding Peripheral Stent
  • Figure 4-44: Class 2 Device Recall Medtronic Abre
  • Figure 4-45: Class 2 Device Recall Medtronic Abre Venous Selfexpanding Sent System
  • Figure 4-46: Class 2 Device Recall ENROUTE Transcarotid Stent System
  • Figure 4-47: Class 2 Device Recall GORE VIABAHN VBX, BALLOON EXPANDABLE ENDOPROSTHESIS
  • Figure 4-48: Class 2 Device Recall Conquest PTA Balloon Dilatation Catheter
  • Figure 4-49: Class 2 Device Recall Conquest 40 PTA Dilatation Catheter
  • Figure 4-50: Class 2 Device Recall Cordis SABER PTA Balloon Dilation Catheter
  • Figure 4-51: Class 2 Device Recall Cordis POWERFLEX P3, PTA Dilation Catheter
  • Figure 4-52: Class 2 Device Recall Cordis MAXI LD PTA Dilatation Catheter
  • Figure 4-53: Class 2 Device Recall POWERFLEX PRO Percutaneous Transluminal Angioplasty (PTA) Catheter
  • Figure 4-54: Class 1 Device Recall ADVANCE ENFORCER 35 FOCAL FORCE PTA BALLOON CATHETER
  • Figure 4-55: Class 2 Device Recall Medtronic IN.PACT Admiral, Paclitaxelcoated PTA Balloon Catheter
  • Figure 4-56: Class 2 Device Recall Chameleon PTA Balloon Dilation Catheter
  • Figure 4-57: Class 2 Device Recall Boston Scientific ROTAPRO
  • Figure 4-58: Class 2 Device Recall STEALTH 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM
  • Figure 4-59: Class 2 Device Recall DIAMONDBACK 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM
  • Figure 4-60: Class 1 Device Recall TurboHawk Plus
  • Figure 4-61: Class 1 Device Recall HawkOne
  • Figure 4-62: Class 2 Device Recall Shockwave Medical Peripheral Intravascular Lithotripsy (IVL) System
  • Figure 4-63: Class 1 Device Recall IntraClude IntraAortic Occlusion Device
  • Figure 4-64: Class 2 Device Recall Intergard Woven Vascular Graft
  • Figure 4-65: Class 2 Device Recall Interavascular SAS/Getinge
  • Figure 4-66: Class 2 Device Recall Hemashield Gold Knitted Bifurcated
  • Figure 4-67: Class 2 Device Recall Atrium ADVANTA VXT Vascular Graft
  • Figure 4-68: Class 2 Device Recall HEMASHIELD MICROVEL Double Velour Knitted Vascular Grafts
  • Figure 4-69: Class 2 Device Recall HEMASHIELD PLATINUM WOVEN/MICROVEL DOUBLE VELOUR VASCULAR GRAFTS
  • Figure 4-70: Class 2 Device Recall HEMASHIELD PLATINUM Woven Double Velour Vascular Graft
  • Figure 4-71: Class 2 Device Recall VASCUTEK/TERUMO
  • Figure 4-72: Class 2 Device Recall Gore Propaten Vascular Graft
  • Figure 4-73: Class 1 Device Recall ENDOLOGIX AFX2 Bifurcated Endograft System
  • Figure 4-74: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Proximal (Aortic) Extension Endograft
  • Figure 4-75: Class 1 Device Recall ENDOLOGIX AFX Endovascular AAA System
  • Figure 4-76: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Limb (Iliac) Extension Endograft
  • Figure 4-77: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft
  • Figure 4-78: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft
  • Figure 4-79: Class 2 Device Recall Zenith Alpha SpiralZ Endovascular Leg
  • Figure 4-80: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft
  • Figure 4-81: Class 2 Device Recall Endurant, Endurant II and Endurant IIs Stent Graft Systems
  • Figure 4-82: Class 2 Device Recall Endurant Stent Graft System
  • Figure 4-83: Class 2 Device Recall Endurant II Stent Graft System
  • Figure 4-84: Class 2 Device Recall Endurant II/IIs Stent Graft System
  • Figure 4-85: Class 2 Device Recall Endurant II/IIs Stent Graft System
  • Figure 4-86: Class 1 Device Recall Valiant Navion Thoracic Stent Graft System
  • Figure 4-87: Class 2 Device Recall EKOS
  • Figure 4-88: Class 2 Device Recall EkoSonic Endovascular Device
  • Figure 4-89: Class 2 Device Recall EKOS Control System
  • Figure 4-90: Class 2 Device Recall AngioJet Ultra Consoles Thrombectomy System
  • Figure 4-91: Class 1 Device Recall ArrowTrerotola PTD
  • Figure 4-92: Class 1 Device Recall ArrowTrerotola Percutaneous Thrombolytic Device
  • Figure 4-93: Class 1 Device Recall ArrowTrerotola OverTheWire PTD Kit Percutaneous Thrombolytic Device: 7FR
  • Figure 4-94: Device Recall AngioJet Ultra 5000 A Console, Boston Scientific
  • Figure 4-95: Class 3 Device Recall Cook
  • Figure 4-96: Class 3 Device Recall Cook Celect Platinum Vena Cava Filter Set
  • Figure 4-97: Class 2 Device Recall SoftVu Omni Flush Angiographic Catheter
  • Figure 4-98: Class 2 Device Recall SEEKER(R) Crossing Support Catheter
  • Figure 4-99: Class 1 Device Recall Imager II 5F Angiographic Catheter
  • Figure 4-100: Class 1 Device Recall SUPER TORQUE MB 5F PIG
  • Figure 4-101: Class 1 Device Recall CrossCath Support Catheter
  • Figure 4-102: Class 2 Device Recall Torcon NB Advantage
  • Figure 4-103: Class 2 Device Recall Amplatz extra Stiff Wire Guide
  • Figure 4-104: Class 2 Device Recall Bentson Wire Guide
  • Figure 4-105: Class 2 Device Recall Cope Mandril Wire Guide
  • Figure 4-106: Class 2 Device Recall Cope Mandril Wire Guide (Nitinol)
  • Figure 4-107: Class 2 Device Recall Coons Interventional Wire Guide
  • Figure 4-108: Class 2 Device Recall Lunderquist Ring Torque Wire Guide
  • Figure 4-109: Class 2 Device Recall Newton Wire Guide
  • Figure 4-110: Class 2 Device Recall Roadrunner PC Hydrophilic Wire Guide
  • Figure 4-111: Class 2 Device Recall Roadrunner PC Wire Guide (Nimble Floppy)
  • Figure 4-112: Class 2 Device Recall Roadrunner PC Wire Guide (The Firm)
  • Figure 4-113: Class 2 Device Recall Cook Roadrunner UniGlide Hydrophilic Wire Guide
  • Figure 4-114: Class 2 Device Recall Cook Roadrunner PC Wire Guide
  • Figure 4-115: Class 2 Device Recall Roadrunner Hydrophilic PC Wire Guide
  • Figure 4-116: Class 2 Device Recall Zurpaz(TM) MEDIUM CURL, ASYMMETRIC CURVE, Steerable Sheath
  • Figure 4-117: Class 2 Device Recall Ultimum HEMOSTASIS INTRODUCER
  • Figure 4-118: Class 2 Device Recall FastCath Trio HEMOSTASIS INTRODUCER
  • Figure 4-119: Class 2 Device Recall FastCath Hemostasis Introducer, HEMOSTASIS INTRODUCER
  • Figure 4-120: Class 2 Device Recall Avanti Catheter Sheath Introducer
  • Figure 4-121: Class 2 Device Recall
  • Figure 4-122: Class 2 Device Recall Flexor CheckFlo Introducer
  • Figure 4-123: Class 1 Device Recall Flexor CheckFlo Introducer
  • Figure 4-124: Class 2 Device Recall Hilal Embolization Microcoil
  • Figure 4-125: Class 2 Device Recall Nester Embolization Microcoil
  • Figure 4-126: Class 2 Device Recall Tornado Embolization Microcoil
  • Figure 4-127: Class 2 Device Recall Terumo AZUR Peripheral Coil System, Detachable 18
  • Figure 4-128: Class 2 Device Recall Terumo AZUR CX Peripheral Coil System, Detachable 35, CX Coil
  • Figure 4-129: Class 2 Device Recall Terumo AZUR CX Peripheral Coil System, Detachable 18, CX Coil
  • Figure 4-130: Class 2 Device Recall OptiCross 35 15 MHz Peripheral Imaging Catheter
  • Figure 4-131: Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or Occlusion
  • Figure 4-132: Belgian Trial Investigating the LifeStream Stent in Complex TASC C and D Iliac Lesions (BELSTREAM)
  • Figure 4-133: Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses (XPEDITE)
  • Figure 4-134: An All-Comers Observational Study of the MicroStent™ Peripheral Vascular Stent System in Subjects With Peripheral Arterial Disease (HEAL)
  • Figure 4-135: SOLARIS Peripheral PMCF Trial
  • Figure 4-136: A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease
  • Figure 4-137: Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access (RADIANCY)
  • Figure 4-138: Stella Supera Siberia
  • Figure 4-139: A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries (REGAL)
  • Figure 4-140: Zilver® PTX® V Clinical Study
  • Figure 4-141: In-Stent Restenosis Post-Approval Study
  • Figure 4-142: BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease (VERNACULAR)
  • Figure 4-143: VIVO Clinical Study
  • Figure 4-144: ULTRASCORE™ Focused Force PTA Balloon Angioplasty for CLI Patients With Below the Knee Vessel Disease
  • Figure 4-145: Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon
  • Figure 4-146: Ranger™ and Ranger™ SL (OTW) DCB in China
  • Figure 4-147: The VaSecure BTK Study
  • Figure 4-148: Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries (RANGER-SFA)
  • Figure 4-149: A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon. (BIOPACT-RCT)
  • Figure 4-150: Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (TRANSCEND)
  • Figure 4-151: RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty (RANGER II SFA)
  • Figure 4-152: IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA
  • Figure 4-153: Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease
  • Figure 4-154: ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study (BTK PMS)
  • Figure 4-155: IN.PACT Global Clinical Study
  • Figure 4-156: ILLUMENATE Pivotal Post-Approval Study (PAS)
  • Figure 4-157: BIOLUX P-III BENELUX All-Comers Registry
  • Figure 4-158: Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter (SAFE-DCB)
  • Figure 4-159: Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy (KAIZEN)
  • Figure 4-160: Jetstream in Treatment of Occlusive Atherosclerotic Lesions in the SFA and/or PPA
  • Figure 4-161: Revascularization of Total or Sub-total Occluded Peripheral Arteries With ByCross® Device. Post Market Clinical Follow-up
  • Figure 4-162: Post-Market Registry of AURYON™ Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease (PATHFINDER-I)
  • Figure 4-163: JET-RANGER Trial - JETStream Atherectomy With Adjunctive Paclitaxel-Coated Balloon Angioplasty vs Plain Old Balloon Angioplasty Followed by Paclitaxel-Coated Balloon
  • Figure 4-164: Pantheris Atherectomy Treatment of In-Stent Restenosis in Lower Extremity Arteries (INSIGHT)
  • Figure 4-165: Safety and Effectiveness Study of Eximo's B-Laser™ Atherectomy Device for PAD Treatment
  • Figure 4-166: Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME II)
  • Figure 4-167: DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions (REALITY)
  • Figure 4-168: Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System
  • Figure 4-169: SOLUTION Trial in China
  • Figure 4-170: Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System (Disrupt PAD+)
  • Figure 4-171: Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
  • Figure 4-172: A Prospective and Retrospective, Multi-Centre, Post-Market, Non-Interventional Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches (PANTHER)
  • Figure 4-173: Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access
  • Figure 4-174: Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study
  • Figure 4-175: Post-Approval Study of the TREO Abdominal Stent-Graft System (TREO PAS)
  • Figure 4-176: The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease
  • Figure 4-177: Zenith Alpha™ Abdominal Endovascular Graft
  • Figure 4-178: Fenestrated AAA Endovascular Graft Post-Approval Study
  • Figure 4-179: transShield Embolic Protection System Feasibility Study
  • Figure 4-180: Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
  • Figure 4-181: Preservation of Venous Valvular Function After PMT for Acute DVT (PREFER)
  • Figure 4-182: A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo Aspiration System (STRIDE)
  • Figure 4-183: FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH)
  • Figure 4-184: JETi Peripheral Thrombectomy Registry (JETi)
  • Figure 4-185: Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever
  • Figure 4-186: Forceps vs. Snare IVC Filter Removal
  • Figure 4-187: Predictors of Attempted Inferior Vena Cava Filters Retrieval
  • Figure 4-188: Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter
  • Figure 4-189: Cook IVC Filter Study (CIVC)
  • Figure 4-190: Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE)
  • Figure 4-191: Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression (ReliaSeal)
  • Figure 4-192: AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial
  • Figure 4-193: Vascular Closure Device in Transcatheter Aortic Valve Replacement
  • Figure 4-195: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA)
  • Figure 4-196: (HALT) Embrace Hydrogel Embolic System (HES) Study of Embolization in Peripheral Arterial Bleeds
  • Figure 4-197: Microvascular Plug (MVP) for the Treatment of Pulmonary ArterioVenous Malformations (PAVMs)
  • Figure 4-198: Use of Interlocking Detachable Coils System in Embolization of Peripheral Arterial Embolization
  • Figure 4-199: CATERPILLAR™ Arterial Embolization Device Study (CHRYSALIS)
  • Figure 4-200: LC Bead LUMI for Prostatic Artery Embolization
  • Figure 5-1: Currency Exchange Rate, 2022
  • Figure 5-2: Peripheral Vascular Device Market by Segment, Europe, 2019 - 2029 (€M) (1 of 3)
  • Figure 5-3: Peripheral Vascular Device Market by Segment, Europe, 2019 - 2029 (€M) (2 of 3)
  • Figure 5-4: Peripheral Vascular Device Market by Segment, Europe, 2019 - 2029 (€M) (3 of 3)
  • Figure 5-5: Peripheral Vascular Device Market by Segment, Europe, 2019 - 2029 (US$M) (1 of 3)
  • Figure 5-6: Peripheral Vascular Device Market by Segment, Europe, 2019 - 2029 (US$M) (2 of 3)
  • Figure 5-7: Peripheral Vascular Device Market by Segment, Europe, 2019 - 2029 (US$M) (3 of 3)
  • Figure 5-8: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022 (1 of 4)
  • Figure 5-9: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022 (2 of 4)
  • Figure 5-10: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022 (3 of 4)
  • Figure 5-11: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022 (4 of 4)
  • Figure 5-12: SWOT Analysis, Abbott (1 of 2)
  • Figure 5-13: SWOT Analysis, Abbott (2 of 2)
  • Figure 5-14: SWOT Analysis, Becton Dickinson (1 of 2)
  • Figure 5-15: SWOT Analysis, Becton Dickinson (2 of 2)
  • Figure 5-16: SWOT Analysis, Boston Scientific
  • Figure 5-17: SWOT Analysis, Cardinal Health
  • Figure 5-18: SWOT Analysis, Cardiovascular Systems, Inc.
  • Figure 5-19: SWOT Analysis, Cook Medical
  • Figure 5-20: SWOT Analysis, Medtronic
  • Figure 5-21: SWOT Analysis, Penumbra
  • Figure 5-22: SWOT Analysis, Philips
  • Figure 5-23: SWOT Analysis, Shockwave Medical
  • Figure 5-24: SWOT Analysis, Silk Road Medical
  • Figure 5-25: SWOT Analysis, Terumo (1 of 2)
  • Figure 5-26: SWOT Analysis, Terumo (2 of 2)
  • Figure 5-27: SWOT Analysis, W.L. Gore
  • Figure 7-1: Peripheral Vascular Device Procedures by Segment, Europe, 2019 - 2029 (1 of 3)
  • Figure 7-2: Peripheral Vascular Device Procedures by Segment, Europe, 2019 - 2029 (2 of 3)
  • Figure 7-3: Peripheral Vascular Device Procedures by Segment, Europe, 2019 - 2029 (3 of 3)
  • Figure 7-4: Peripheral Vascular Stent Procedures by Country, Europe, 2019 - 2029
  • Figure 7-5: Arterial Stent Procedures by Device Type, Europe, 2019 - 2029
  • Figure 7-6: Arterial Stent Procedures by Country, Europe, 2019 - 2029
  • Figure 7-7: Bare-Metal Stent Procedures by Indication, Europe, 2019 - 2029
  • Figure 7-8: Bare-Metal Stent Procedures by Country, Europe, 2019 - 2029
  • Figure 7-9: Bare-Metal Carotid Stent Procedures by Country, Europe, 2019 - 2029
  • Figure 7-10: Bare-Metal Iliac Stent Procedures by Country, Europe, 2019 - 2029
  • Figure 7-11: Bare-Metal Renal Stent Procedures by Country, Europe, 2019 - 2029
  • Figure 7-12: Bare-Metal Fem-Pop Stent Procedures by Country, Europe, 2019 - 2029
  • Figure 7-13: Bare-Metal Infra-Pop Stent Procedures by Country, Europe, 2019 - 2029
  • Figure 7-14: Covered Stent Procedures by Indication, Europe, 2019 - 2029
  • Figure 7-15: Covered Stent Procedures by Country, Europe, 2019 - 2029
  • Figure 7-16: Iliac Covered Stent Procedures by Country, Europe, 2019 - 2029
  • Figure 7-17: Fem-Pop Covered Stent Procedures by Country, Europe, 2019 - 2029
  • Figure 7-18: AV Access Covered Stent Procedures by Country, Europe, 2019 - 2029
  • Figure 7-19: Drug-Eluting Stent Procedures by Indication, Europe, 2019 - 2029
  • Figure 7-20: Drug-Eluting Stent Procedures by Country, Europe, 2019 - 2029
  • Figure 7-21: SFA Drug-Eluting Stent Procedures by Country, Europe, 2019 - 2029
  • Figure 7-22: Infra-Pop Drug-Eluting Stent Procedures by Country, Europe, 2019 - 2029
  • Figure 7-23: Venous Stent Procedures by Country, Europe, 2019 - 2029
  • Figure 7-24: PTA Balloon Catheter Procedures by Country, Europe, 2019 - 2029
  • Figure 7-25: Drug-Coated Balloon Procedures by Country, Europe, 2019 - 2029
  • Figure 7-26: Atherectomy Device Procedures by Device Type, Europe, 2019 - 2029
  • Figure 7-27: Atherectomy Device Procedures by Country, Europe, 2019 - 2029
  • Figure 7-28: Laser Atherectomy Device Procedures by Country, Europe, 2019 - 2029
  • Figure 7-29: Mechanical Atherectomy Device Procedures by Country, Europe, 2019 - 2029
  • Figure 7-30: Intravascular Lithotripsy Procedures by Device Type, Europe, 2019 - 2029
  • Figure 7-31: Intravascular Lithotripsy Procedures by Country, Europe, 2019 - 2029
  • Figure 7-32: SFA and Iliac Lithotripsy Procedures by Country, Europe, 2019 - 2029
  • Figure 7-33: BTK Lithotripsy Procedures by Country, Europe, 2019 - 2029
  • Figure 7-34: CTO Device Procedures by Device Type, Europe, 2019 - 2029
  • Figure 7-35: CTO Device Procedures by Country, Europe, 2019 - 2029
  • Figure 7-36: Re-Entry CTO Procedures by Country, Europe, 2019 - 2029
  • Figure 7-37: Recanalization CTO Procedures by Country, Europe, 2019 - 2029
  • Figure 7-38: Total Surgical Graft Procedures by Material, Europe, 2019 - 2029
  • Figure 7-39: Total Surgical Graft Procedures by Country, Europe, 2019 - 2029
  • Figure 7-40: Polyester Surgical Graft Procedures by Country, Europe, 2019 - 2029
  • Figure 7-41: ePTFE Surgical Graft Procedures by Country, Europe, 2019 - 2029
  • Figure 7-42: Total Surgical Graft Procedures by Indication, Europe, 2019 - 2029
  • Figure 7-43: Lower-Limb Surgical Graft Procedures by Country, Europe, 2019 - 2029
  • Figure 7-44: Above-the-Knee Surgical Graft Procedures by Country, Europe, 2019 - 2029
  • Figure 7-45: Below-the-Knee Surgical Graft Procedures by Country, Europe, 2019 - 2029
  • Figure 7-46: AV Access Surgical Graft Procedures by Country, Europe, 2019 - 2029
  • Figure 7-47: Aorta Repair Surgical Graft Procedures by Country, Europe, 2019 - 2029
  • Figure 7-48: Abdominal Aortic Aneurysm Surgical Graft Procedures by Country, Europe, 2019 - 2029
  • Figure 7-49: Thoracic Aortic Aneurysm Surgical Graft Procedures by Country, Europe, 2019 - 2029
  • Figure 7-50: Extra-Anatomical Bypass Surgical Graft Procedures by Country, Europe, 2019 - 2029
  • Figure 7-51: Stent Graft Procedures by Device Type, Europe, 2019 - 2029
  • Figure 7-52: Stent Graft Procedures by Country, Europe, 2019 - 2029
  • Figure 7-53: AAA Stent Graft Procedures by Country, Europe, 2019 - 2029
  • Figure 7-54: Fenestrated Stent Graft Procedures by Country, Europe, 2019 - 2029
  • Figure 7-55: TAA Stent Graft Procedures by Country, Europe, 2019 - 2029
  • Figure 7-56: Embolic Protection Device Procedures by Device Type, Europe, 2019 - 2029
  • Figure 7-57: Embolic Protection Device Procedures by Country, Europe, 2019 - 2029
  • Figure 7-58: Carotid EPD Procedures by Country, Europe, 2019 - 2029
  • Figure 7-59: Renal EPD Procedures by Country, Europe, 2019 - 2029
  • Figure 7-60: Lower-Limb EPD Procedures by Country, Europe, 2019 - 2029
  • Figure 7-61: Peripheral Thrombus Management Procedures by Device Type, Europe, 2019 - 2029
  • Figure 7-62: Peripheral Thrombus Management Procedures by Country, Europe, 2019 - 2029
  • Figure 7-63: Traditional Thrombectomy Device Procedures by Country, Europe, 2019 - 2029
  • Figure 7-64: Pharmacomechanical Thrombectomy Device Procedures by Country, Europe, 2019 - 2029
  • Figure 7-67: Retrievable IVCF Procedures by Country, Europe, 2019 - 2029
  • Figure 7-68: Permanent IVCF Procedures by Country, Europe, 2019 - 2029
  • Figure 7-69: Carotid Shunt Procedures by Country, Europe, 2019 - 2029
  • Figure 7-70: Total Vascular Closure Device Procedures by Device Type, Europe, 2019 - 2029
  • Figure 7-71: Total Vascular Closure Device Procedures by Country, Europe, 2019 - 2029
  • Figure 7-72: Small-Bore Invasive VCD Procedures by Country, Europe, 2019 - 2029
  • Figure 7-73: Large-Bore Invasive VCD Procedures by Country, Europe, 2019 - 2029
  • Figure 7-74: Non-Invasive VCD Procedures by Country, Europe, 2019 - 2029
  • Figure 7-75: Total VCD Procedures by Approach, Europe, 2019 - 2029
  • Figure 7-76: Radial VCD Procedures by Country, Europe, 2019 - 2029
  • Figure 7-77: Femoral VCD Procedures by Country, Europe, 2019 - 2029
  • Figure 7-78: Transcatheter Embolization Procedures by Device Type, Europe, 2019 - 2029
  • Figure 7-79: Transcatheter Embolization Procedures by Country, Europe, 2019 - 2029
  • Figure 7-80: Particle Embolization Procedures by Device Type, Europe, 2019 - 2029
  • Figure 7-81: Particle Embolization Procedures by Country, Europe, 2019 - 2029
  • Figure 7-82: PVA Particle Procedures by Country, Europe, 2019 - 2029
  • Figure 7-83: Microsphere Procedures by Country, Europe, 2019 - 2029
  • Figure 7-84: Drug-Eluting Particle Procedures by Country, Europe, 2019 - 2029
  • Figure 7-85: Radioactive Particle Procedures by Country, Europe, 2019 - 2029
  • Figure 7-86: Coil Embolization Procedures by Device Type, Europe, 2019 - 2029
  • Figure 7-87: Coil Embolization Procedures by Country, Europe, 2019 - 2029
  • Figure 7-88: Pushable Coil Procedures by Country, Europe, 2019 - 2029
  • Figure 7-89: Detachable Coil Procedures by Country, Europe, 2019 - 2029
  • Figure 7-90: Liquid Embolics Procedures by Country, Europe, 2019 - 2029
  • Figure 7-91: Plug Embolization Procedures by Country, Europe, 2019 - 2029
  • Figure 7-92: Peripheral IVUS Procedures by Country, Europe, 2019 - 2029
  • Figure 8-1: Peripheral Vascular Stent Market by Segment, Europe, 2019 - 2029 (€M)
  • Figure 8-2: Peripheral Vascular Stent Market by Segment, Europe, 2019 - 2029 (US$M)
  • Figure 8-3: Arterial Stent Market by Device Type, Europe, 2019 - 2029 (€M)
  • Figure 8-4: Arterial Stent Market by Device Type, Europe, 2019 - 2029 (US$M)
  • Figure 8-5: Arterial Stent Market, Europe, 2019 - 2029
  • Figure 8-6: Units Sold by Country, Arterial Stent Market, Europe, 2019 - 2029
  • Figure 8-7: Average Selling Price by Country, Arterial Stent Market, Europe, 2019 - 2029 (€)
  • Figure 8-8: Average Selling Price by Country, Arterial Stent Market, Europe, 2019 - 2029 (US$)
  • Figure 8-9: Market Value by Country, Arterial Stent Market, Europe, 2019 - 2029 (€M)
  • Figure 8-10: Market Value by Country, Arterial Stent Market, Europe, 2019 - 2029 (US$M)
  • Figure 8-11: Bare-Metal Stent Market by Indication, Europe, 2019 - 2029 (€M)
  • Figure 8-12: Bare-Metal Stent Market by Indication, Europe, 2019 - 2029 (US$M)
  • Figure 8-13: Total Bare-Metal Stent Market, Europe, 2019 - 2029
  • Figure 8-14: Units Sold by Country, Total Bare-Metal Stent Market, Europe, 2019 - 2029
  • Figure 8-15: Average Selling Price by Country, Total Bare-Metal Stent Market, Europe, 2019 - 2029 (€)
  • Figure 8-16: Average Selling Price by Country, Total Bare-Metal Stent Market, Europe, 2019 - 2029 (US$)
  • Figure 8-17: Market Value by Country, Total Bare-Metal Stent Market, Europe, 2019 - 2029 (€M)
  • Figure 8-18: Market Value by Country, Total Bare-Metal Stent Market, Europe, 2019 - 2029 (US$M)
  • Figure 8-19: Bare-Metal Carotid Stent Market, Europe, 2019 - 2029
  • Figure 8-20: Units Sold by Country, Bare-Metal Carotid Stent Market, Europe, 2019 - 2029
  • Figure 8-21: Average Selling Price by Country, Bare-Metal Carotid Stent Market, Europe, 2019 - 2029 (€)
  • Figure 8-22: Average Selling Price by Country, Bare-Metal Carotid Stent Market, Europe, 2019 - 2029 (US$)
  • Figure 8-23: Market Value by Country, Bare-Metal Carotid Stent Market, Europe, 2019 - 2029 (€M)
  • Figure 8-24: Market Value by Country, Bare-Metal Carotid Stent Market, Europe, 2019 - 2029 (US$M)
  • Figure 8-25: Bare-Metal Iliac Stent Market, Europe, 2019 - 2029
  • Figure 8-26: Units Sold by Country, Bare-Metal Iliac Stent Market, Europe, 2019 - 2029
  • Figure 8-27: Average Selling Price by Country, Bare-Metal Iliac Stent Market, Europe, 2019 - 2029 (€)
  • Figure 8-28: Average Selling Price by Country, Bare-Metal Iliac Stent Market, Europe, 2019 - 2029 (US$)
  • Figure 8-29: Market Value by Country, Bare-Metal Iliac Stent Market, Europe, 2019 - 2029 (€M)
  • Figure 8-30: Market Value by Country, Bare-Metal Iliac Stent Market, Europe, 2019 - 2029 (US$M)
  • Figure 8-31: Bare-Metal Renal Stent Market, Europe, 2019 - 2029
  • Figure 8-32: Units Sold by Country, Bare-Metal Renal Stent Market, Europe, 2019 - 2029
  • Figure 8-33: Average Selling Price by Country, Bare-Metal Renal Stent Market, Europe, 2019 - 2029 (€)
  • Figure 8-34: Average Selling Price by Country, Bare-Metal Renal Stent Market, Europe, 2019 - 2029 (US$)
  • Figure 8-35: Market Value by Country, Bare-Metal Renal Stent Market, Europe, 2019 - 2029 (€M)
  • Figure 8-36: Market Value by Country, Bare-Metal Renal Stent Market, Europe, 2019 - 2029 (US$M)
  • Figure 8-37: Bare-Metal Fem-Pop Stent Market, Europe, 2019 - 2029
  • Figure 8-38: Units Sold by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 - 2029
  • Figure 8-39: Average Selling Price by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 - 2029 (€)
  • Figure 8-40: Average Selling Price by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 - 2029 (US$)
  • Figure 8-41: Market Value by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 - 2029 (€M)
  • Figure 8-42: Market Value by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 - 2029 (US$M)
  • Figure 8-43: Bare-Metal Infra-Pop Stent Market, Europe, 2019 - 2029
  • Figure 8-44: Units Sold by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 - 2029
  • Figure 8-45: Average Selling Price by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 - 2029 (€)
  • Figure 8-46: Average Selling Price by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 - 2029 (US$)
  • Figure 8-47: Market Value by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 - 2029 (€M)
  • Figure 8-48: Market Value by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 - 2029 (US$M)
  • Figure 8-49: Covered Stent Market, Europe, 2019 - 2029
  • Figure 8-50: Units Sold by Country, Covered Stent Market, Europe, 2019 - 2029
  • Figure 8-51: Average Selling Price by Country, Covered Stent Market, Europe, 2019 - 2029 (€)
  • Figure 8-52: Average Selling Price by Country, Covered Stent Market, Europe, 2019 - 2029 (US$)
  • Figure 8-53: Market Value by Country, Covered Stent Market, Europe,
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!